Triheptanoin
H-8-2014-006
Phase 2 small_molecule completed
Quick answer
Triheptanoin for Glycogen Storage Disease Type V is a Phase 2 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Glycogen Storage Disease Type V
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed